- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2007
- Public Summary Document (PSD) November 2007 PBAC Meeting - PDF
Natalizumab – November 2007
Natalizumab, concentrated solution for IV infusion, 300 mg per 15 mL, Tysabri, November 2007
Last updated
29 February 2008